Kyla Mckay
Biträdande Lektor
E-postadress: kyla.mckay@ki.se
Besöksadress: Eugeniahemmet, Maria Aspmans gata 30 A, 17176 Stockholm
Postadress: K8 Klinisk neurovetenskap, K8 Neuro Fink/McKay, 171 77 Stockholm
Om mig
- Postdoktor
*Postdoctoral Research Fellowship Exchange Award* - European Committee for
Treatment and Research in Multiple Sclerosis (ECTRIMS) – September 2017
*Postdoctoral Fellowship Award* - Canadian Institutes of Health Research –
September 2017
*PhD* in Experimental Medicine - University of British Columbia, Vancouver,
British Columbia, Canada (June 2017)
*Bachelor of Science* – Major in Neuroscience - Dalhousie University,
Halifax, Nova Scotia, Canada (May 2008)
Forskningsbeskrivning
- Mellan 3 och 10% av personer med MS upplever sina första neurologiska
symptom i barndomen. Även om det är mindre vanligt än MS hos vuxna, är
det speciellt problematiskt för patienterna och deras familjer. Det
generella syftet med den föreslagna forskningen att tillhandahålla
evidensbaserad information för att hjälpa vid vård av barn med MS och att
guida framtida observationsstudier genom att i) beskriva demografiska och
kliniska egenskaper - ii) undersöka potentiella miljö- och genetiska
riskfaktorer, iii) undersöka långsiktiga sociala och ekonomiska
konsekvenser, iv) undersöka säkerheten och effektiviteten hos MS-specifika
behandlingar för MS hos barn."
Artiklar
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(6):1393-1404
- Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(5):e16253
- Article: NEUROLOGY. 2024;102(6):e208051
- Article: ANNALS OF NEUROLOGY. 2024;95(3):487-494
- Article: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. 2024;95(3):229-234
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2024;53(1):dyad184
- Article: FRONTIERS IN PUBLIC HEALTH. 2024;12:1331746
- Article: JAMA NETWORK OPEN. 2023;6(9):e2334675
- Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(9):1126-1135
- Article: NEUROLOGY. 2023;101(5):e522-e532
- Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(6):731-740
- Article: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. 2023;94(4):284-289
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e198
- Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2022;8(4):20552173221144230
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(9):1449-1458
- Journal article: INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE. 2022;7(3):1804
- Article: MULTIPLE SCLEROSIS JOURNAL. 2022;28(7):1051-1059
- Journal article: NEUROLOGY. 2022;98(18_supplement)
- Article: ANNALS OF NEUROLOGY. 2022;91(3):417-423
- Article: ACTA NEUROLOGICA SCANDINAVICA. 2021;144(6):680-686
- Article: SCIENTIFIC REPORTS. 2021;11(1):18528
- Journal article: NEUROLOGY. 2021;96(15_supplement)
- Article: JAMA NEUROLOGY. 2021;78(4):478-482
- Article: NEUROLOGY: NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2020;7(6):e903
- Article: NEUROLOGY. 2020;94(9):E932-E941
- Article: NEUROLOGY. 2019;93(24):E2216-E2223
- Article: JAMA NEUROLOGY. 2019;76(9):1028-1034
- Article: NEUROLOGY. 2019;92(24):E2764-E2773
- Article: JOURNAL OF NEUROLOGY. 2019;266(2):481-486
- Article: NEUROLOGY. 2018;90(15):e1316-e1323
- Journal article: INTERNATIONAL JOURNAL OF MS CARE. 2018;20(2):76-84
- Journal article: NEUROEPIDEMIOLOGY. 2018;51(1-2):1-10
- Article: NEUROLOGY. 2017;89(24):2455-2461
- Article: NEUROTOXICOLOGY. 2017;61:243-264
- Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(4):588-596
- Article: INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE. 2017;86(1):28
- Article: NEUROEPIDEMIOLOGY. 2017;48(3-4):124-130
- Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(6):1093-1100
- Article: NEUROLOGY. 2016;86(15):1417-1424
- Journal article: NEUROLOGY. 2016;86(16_supplement)
- Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(5):685-693
- Article: INTERNATIONAL JOURNAL OF MS CARE. 2016;18(2):96-104
- Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2015;4(5):470-476
- Journal article: NEUROLOGY. 2015;84(14_supplement)
- Visa fler
Alla övriga publikationer
- Letter: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2024;88:105726
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:202-203
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:1045-1046
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:429-430
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:11-12
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:777
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:173-174
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:169-170
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:1083-1084
- Review: BMC MEDICINE. 2022;20(1):251
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):438
- Editorial comment: MULTIPLE SCLEROSIS JOURNAL. 2022;28(1):3-6
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):178-179
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):169-170
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):212
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):460
- Letter: JAMA NETWORK OPEN. 2021;4(12):e2136697
- Preprint: SSRN ELECTRONIC JOURNAL. 2021
- Book chapter: NEUROIMMUNOLOGY. 2021;p. 137-153
- Conference publication: NEUROLOGY. 2021;96(15)
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):763-764
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):60-61
- Review: ACTA NEUROLOGICA SCANDINAVICA. 2021;143(1):39-50
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):257
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):137-138
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:396-397
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:375-376
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:693
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:540-541
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:406-407
- Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;20:169-177
- Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(2):133-139
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:542
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:41
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:544
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:665-666
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:469-470
- Review: NEUROTOXICOLOGY. 2017;61:266-289
- Review: NEUROTOXICOLOGY. 2017;61:189-212
- Editorial comment: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2017;12:1-3
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:25
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:991
- Conference publication: NEUROLOGY. 2016;86
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:339-340
- Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2016;5:53-65
- Editorial comment: LANCET NEUROLOGY. 2015;14(3):237-238
- Review: BIOMED RESEARCH INTERNATIONAL. 2015;2015:817238-11
- Visa fler
Forskningsbidrag
- Swedish Research Council for Health Working Life and Welfare1 January 2020 - 31 December 2021
- Swedish Research Council1 January 2019 - 31 December 2021
- The causes and consequences of paediatric multiple sclerosis: A population-based studyCanadian Institutes of Health Research1 September 2017 - 31 December 2020
- Using linked health data to investigate the impact of psychiatric comorbidity on disability progression in multiple sclerosisCanadian Institutes of Health Research1 May 2016 - 5 July 2017